Cape Verde vs South Africa: Share of the population living with HIV receiving antiretroviral therapy
Cape Verde
80.3%
in 2024
South Africa
80.6%
in 2024
Cape Verde rank
51st
South Africa rank
50th
Share of the population living with HIV receiving antiretroviral therapy over time
- Cape Verde
- South Africa
How they compare
South Africa currently reports 80.6% against 80.3% in Cape Verde, a difference of 0.3%.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was South Africa ahead.
Cape Verde ranks 51st and South Africa ranks 50th of 149 countries.
Cape Verde has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cape Verde | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 9.6% | 5.6% | 4.0% | Cape Verde |
| 2010s | 51.4% | 51.4% | 0.0% | Cape Verde |
| 2020s | 78.6% | 78.0% | 0.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Cape Verde or South Africa?
- South Africa, at 80.6% against 80.3% in Cape Verde as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Cape Verde and South Africa?
- 0.3%, with South Africa ahead.
- How many years of comparable data are there for Cape Verde and South Africa?
- 35 years are reported by both, from 1990 to 2024.
- How do Cape Verde and South Africa rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Cape Verde ranks 51st and South Africa ranks 50th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.